Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical ...

Eli Lilly (LLY +0.44%) took another big swipe at America's rebate-hungry reimbursement system by launching a generic competitor for two more of its popular insulin lispro containing products. Diabetes ...

A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...

Consumer Reports has no financial relationship with advertisers on this site. Faced with skyrocketing costs for insulin to treat his type 1 diabetes and limited insurance options, earlier this month ...

While Eli Lilly’s generic insulin has been approved since March, a significant portion of prescription claims are still for its brand-name counterpart, Humalog, according to an analysis from drug ...

Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. At 50% the price of Humalog, ...

Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks. Pharmaceutical company Eli ...